Foundation For Innovative New Diagnostics, Switzerland
Clinical trials sponsored by Foundation For Innovative New Diagnostics, Switzerland, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a simple breath test replace needles for malaria diagnosis? Results expected Nov 2026 (estimated)
- New TB test could speed up detection of Drug-Resistant strains Results expected Jun 2027 (estimated)
-
Can skin sensors replace finger pricks for diabetes care in kenya?
Disease control PausedResearchers in Kenya are studying whether continuous glucose monitors help people with type 1 diabetes control their blood sugar better than standard finger-prick testing. The trial enrolls about 246 people with type 1 diabetes, including children and adolescents, at three clinic…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Disease control
Last updated Sep 21, 2026 13:00 UTC
-
Dry swabs could simplify HPV screening
Diagnosis PausedResearchers compare two ways to collect vaginal samples for high-risk HPV testing: swabs stored dry and swabs stored in liquid. The study enrolls 1,306 women aged 30 and older who have abnormal cervical screening results. The goal is to see if dry swabs detect HPV as accurately a…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New TB test could speed up detection of Drug-Resistant strains
Diagnosis OngoingThis study evaluates a new PCR test (Bioneer Q-RFIA kit) for quickly and accurately detecting tuberculosis (TB) and resistance to key antibiotics. About 2,350 adults with TB symptoms will provide samples to see how well the test works compared to standard methods. The goal is to …
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC